• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在小鼠体内,具有强大 κ 阿片受体拮抗作用的诺比那肽呈现出持久药效的药代动力学证据。

Pharmacokinetic evidence for the long-lasting effect of nor-binaltorphimine, a potent kappa opioid receptor antagonist, in mice.

机构信息

Department of Pharmacology, Wakayama Medical University, Wakayama-City, Wakayama 641-8509, Japan.

出版信息

Neurosci Lett. 2013 Sep 27;552:98-102. doi: 10.1016/j.neulet.2013.07.040. Epub 2013 Aug 7.

DOI:10.1016/j.neulet.2013.07.040
PMID:23933210
Abstract

Nor-binaltorphimine (nor-BNI) is kappa opioid receptor (KOR) antagonist with the extremely long duration in mice analgesic assay, in vivo. For the evaluation of long-lasting effect of nor-BNI, brain content and serum concentration of nor-BNI were quantified in comparison with those of naloxone (a short-acting non-specific opioid receptor antagonist) by high-performance liquid chromatography with electrochemical detector in mice. After concomitant administration (20 mg/kg, s.c.) of nor-BNI and naloxone, nor-BNI in brain and serum showed biphasic elimination, with a rapid phase for 0.75-4 h and a slow phase for 4-48 h. Elimination rate in brain was slower than that of serum. Naloxone in brain and serum was detected for 3 h and 4 h, respectively. The brain/serum ratio of nor-BNI gradually increased over 0.75-48 h, while that of naloxone rapidly declined. After concomitant administration (30 mg/kg, s.c.) of nor-BNI and naloxone, brain nor-BNI was detected in all mice from day 1 to day 21 and in two of six mice at day 28, while serum nor-BNI was detected in all mice at day 1, three of seven at day 3 and one of six at day 7. After that, serum nor-BNI was not detected. Naloxone in brain and serum was not detected at day 1. These results provide pharmacokinetic support for the long-lasting antagonistic effects of nor-BNI.

摘要

在体内小鼠镇痛试验中,去甲纳曲酮(nor-BNI)是一种κ阿片受体(KOR)拮抗剂,具有极长的作用持续时间。为了评估 nor-BNI 的长效作用,通过高效液相色谱电化学检测法比较了 nor-BNI 和纳洛酮(一种短效非特异性阿片受体拮抗剂)在小鼠中的脑含量和血清浓度。在同时给予 nor-BNI(20mg/kg,sc)和纳洛酮后,脑和血清中的 nor-BNI 呈双相消除,快速相为 0.75-4 h,缓慢相为 4-48 h。脑内消除速率比血清慢。脑内和血清中的纳洛酮分别检测到 3 h 和 4 h。脑/血清中 nor-BNI 的比值在 0.75-48 h 内逐渐增加,而纳洛酮的比值迅速下降。在同时给予 nor-BNI(30mg/kg,sc)和纳洛酮后,所有小鼠在第 1 天至第 21 天都检测到脑内 nor-BNI,6 只小鼠中有 2 只在第 28 天仍能检测到,而血清 nor-BNI 则在所有小鼠在第 1 天都能检测到,7 只中有 3 只在第 3 天,6 只中有 1 只在第 7 天仍能检测到。此后,血清 nor-BNI 未能检测到。脑内和血清中的纳洛酮在第 1 天都未能检测到。这些结果为 nor-BNI 的长效拮抗作用提供了药代动力学支持。

相似文献

1
Pharmacokinetic evidence for the long-lasting effect of nor-binaltorphimine, a potent kappa opioid receptor antagonist, in mice.在小鼠体内,具有强大 κ 阿片受体拮抗作用的诺比那肽呈现出持久药效的药代动力学证据。
Neurosci Lett. 2013 Sep 27;552:98-102. doi: 10.1016/j.neulet.2013.07.040. Epub 2013 Aug 7.
2
Physical presence of nor-binaltorphimine in mouse brain over 21 days after a single administration corresponds to its long-lasting antagonistic effect on κ-opioid receptors.单次给药 21 天后,诺比那肽在小鼠脑中的存在对应于其对 κ 阿片受体的持久拮抗作用。
J Pharmacol Exp Ther. 2013 Sep;346(3):545-54. doi: 10.1124/jpet.113.206086. Epub 2013 Jul 12.
3
Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo.诺-纳曲酮:一种强效且选择性的κ-阿片受体拮抗剂,在体内具有持久活性。
Arch Int Pharmacodyn Ther. 1992 Mar-Apr;316:30-42.
4
Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity.长效κ阿片受体拮抗剂诺BNI、GNTI和JDTic:小鼠体内药代动力学及亲脂性
BMC Pharmacol. 2012 May 29;12:5. doi: 10.1186/1471-2210-12-5.
5
Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.纳洛酮能在预先短暂给予GM1神经节苷脂的未接触过药物的小鼠或慢性吗啡依赖小鼠中迅速诱发内源性κ阿片受体介导的痛觉过敏。
Brain Res. 2007 Sep 5;1167:31-41. doi: 10.1016/j.brainres.2007.06.058. Epub 2007 Jul 14.
6
Effects of ICI204,448, naloxone methiodide and levocetirizine on the scratching behavior induced by a κ-opioid antagonist, nor-BNI, in ICR mice.ICI204,448、甲硫碘化纳洛酮和左西替利嗪对ICR小鼠中由κ-阿片受体拮抗剂nor-BNI诱导的抓挠行为的影响。
Immunopharmacol Immunotoxicol. 2017 Oct;39(5):292-295. doi: 10.1080/08923973.2017.1354879. Epub 2017 Jul 26.
7
Longer occupancy of opioid receptors by nalmefene compared to naloxone as measured in vivo by a dual-detector system.通过双探测器系统在体内测量发现,与纳洛酮相比,纳美芬对阿片受体的占据时间更长。
J Nucl Med. 1997 Nov;38(11):1726-31.
8
Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test.在小鼠甩尾试验中,诺-纳曲酮(nor-BNI)具有极其持久的拮抗作用。
J Pharmacol Exp Ther. 1992 Mar;260(3):1237-43.
9
Central kappa-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: behavioral and BDNF mRNA expression studies.中枢κ-阿片受体介导的诺-纳洛酮啡肽的抗抑郁样作用:行为学和脑源性神经营养因子mRNA表达研究。
Eur J Pharmacol. 2007 Sep 10;570(1-3):89-96. doi: 10.1016/j.ejphar.2007.05.045. Epub 2007 Jun 9.
10
A novel, potent, oral active and safe antinociceptive pyrazole targeting kappa opioid receptors.一种新型、强效、口服活性且安全的针对κ阿片受体的镇痛吡唑类药物。
Neuropharmacology. 2013 Oct;73:261-73. doi: 10.1016/j.neuropharm.2013.06.011. Epub 2013 Jun 18.

引用本文的文献

1
Effects of a kappa opioid receptor antagonist on delayed postoperative pain recovery in a novel mouse sleep disorder model.κ阿片受体拮抗剂对新型小鼠睡眠障碍模型术后疼痛延迟恢复的影响。
Front Pain Res (Lausanne). 2025 Jul 4;6:1516935. doi: 10.3389/fpain.2025.1516935. eCollection 2025.
2
The ultrasonic vocalization (USV) syllable profile during neonatal opioid withdrawal and a kappa opioid receptor component to increased USV emissions in female mice.新生小鼠阿片类药物戒断期间的超声发声(USV)音节特征以及κ阿片受体成分对雌性小鼠USV排放增加的影响。
Psychopharmacology (Berl). 2025 Feb;242(2):427-447. doi: 10.1007/s00213-024-06694-7. Epub 2024 Sep 30.
3
Xylazine is an agonist at kappa opioid receptors and exhibits sex-specific responses to opioid antagonism.
赛拉嗪是一种κ阿片受体激动剂,对阿片类拮抗作用表现出性别特异性反应。
Addict Neurosci. 2024 Jun;11. doi: 10.1016/j.addicn.2024.100155. Epub 2024 May 3.
4
The ultrasonic vocalization (USV) syllable profile during neonatal opioid withdrawal and a kappa opioid receptor component to increased USV emissions in female mice.新生小鼠阿片类药物戒断期间的超声发声(USV)音节特征以及κ阿片受体成分对雌性小鼠USV排放量增加的影响。
bioRxiv. 2024 Sep 1:2024.07.02.601766. doi: 10.1101/2024.07.02.601766.
5
Antagonism of kappa opioid receptors accelerates the development of L-DOPA-induced dyskinesia in a preclinical model of moderate dopamine depletion.κ 阿片受体拮抗剂加速了中度多巴胺耗竭的临床前模型中 L-DOPA 诱导的运动障碍的发展。
Brain Res. 2023 Dec 15;1821:148613. doi: 10.1016/j.brainres.2023.148613. Epub 2023 Sep 30.
6
Systemic kappa opioid receptor antagonism accelerates reinforcement learning via augmentation of novelty processing in male mice.系统 κ 阿片受体拮抗作用通过增强雄性小鼠新奇处理来加速强化学习。
Neuropsychopharmacology. 2023 May;48(6):857-868. doi: 10.1038/s41386-023-01547-x. Epub 2023 Feb 17.
7
Adverse Effects of Repeated, Intravenous Morphine on Recovery after Spinal Cord Injury in Young, Male Rats Are Blocked by a Kappa Opioid Receptor Antagonist.反复静脉注射吗啡对年轻雄性大鼠脊髓损伤后恢复的不良影响可被κ阿片受体拮抗剂阻断。
J Neurotrauma. 2022 Dec;39(23-24):1741-1755. doi: 10.1089/neu.2022.0208. Epub 2022 Oct 5.
8
Kappa Opioid Receptor Blockade in the Amygdala Mitigates Pain Like-Behaviors by Inhibiting Corticotropin Releasing Factor Neurons in a Rat Model of Functional Pain.杏仁核中的κ阿片受体阻断通过抑制功能性疼痛大鼠模型中的促肾上腺皮质激素释放因子神经元来减轻疼痛样行为。
Front Pharmacol. 2022 May 25;13:903978. doi: 10.3389/fphar.2022.903978. eCollection 2022.
9
Sex Differences in Kappa Opioid Receptor Agonist Mediated Attenuation of Chemotherapy-Induced Neuropathic Pain in Mice.κ阿片受体激动剂介导减轻小鼠化疗诱导的神经性疼痛中的性别差异
Front Pharmacol. 2022 Feb 18;13:813562. doi: 10.3389/fphar.2022.813562. eCollection 2022.
10
The Role of Dynorphin and the Kappa Opioid Receptor in Schizophrenia and Major Depressive Disorder: A Translational Approach.强啡肽与κ阿片受体在精神分裂症和重性抑郁症中的作用:一种转化研究方法。
Handb Exp Pharmacol. 2022;271:525-546. doi: 10.1007/164_2020_396.